In terms of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD 1/P/CIR/2023/123 dated July 13, 2023, JHS Svendgaard Laboratories has informed that the Board of Directors of the Company at their meeting held on Monday, August 12, 2024, considered and approved the following businesses: A. The Un-audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended 30th June, 2024. The company has enclosed are the following documents in respect of the items transacted in the meeting: 1. The Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024. 2. Limited Review Reports issued by the Statutory Auditors on such Financial Results. This disclosure along with the enclosures shall be made available on the website of the Company: https://www.svendgaard.com. The Board Meeting commenced at 01:33 pm and concluded at 3:10 pm.
The above information is a part of company’s filings submitted to BSE.
